Plain-English translation of NCT06557551 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Babies born before 28 weeks of pregnancy often struggle to breathe because their lungs are not fully developed. This trial tests whether giving a medication called Curosurf through a thin breathing tube shortly after birth—before babies start other breathing support—helps them avoid serious lung problems. The thin tube is removed immediately after the medication is delivered, so babies don't need to stay on a ventilator.
Doctors currently wait to give this lung medication only after babies show they need it. This trial wants to know if giving the treatment earlier, right at birth, could prevent breathing problems from developing in the first place—especially in the tiniest, most fragile babies.
You likely qualify if…
You likely don't qualify if…
If your baby is randomly assigned to receive the new treatment, at 5 minutes or later after birth, a doctor will gently insert a very thin breathing tube into your baby's windpipe using a special camera to guide it. Curosurf medication will be delivered through this tube, then the tube is removed right away. Your baby continues receiving standard breathing support (oxygen and pressure support through a mask). If your baby is in the standard care group, your baby receives the usual breathing support and medication only if needed later.
AI-generated summary from trial data · Aug 29, 2026 · Not medical advice
Ireland